---
$id: https://graph.org.ai/products/commodity/51131650
$type: Product
source: UNSPSC
code: "51131650"
title: "Rivaroxaban"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rivaroxaban

**UNSPSC Code**: 51131650
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent with the molecular formula C19H18ClN3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9NDF7JZ4M3, chemically known as 5-chloro-n-(((5s)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide but generally known as rivaroxaban, which bears US NIH Compound Identifier 6433119. European Medicines Agency schedules Rivaroxaban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29263. The term RIVAROXABAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, No. 3, 2004, List 52). World Health Organization schedules rivaroxaban in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule rivaroxaban under HS 29349990 and SITC 51579. As of Q4 2014, RIVAROXABAN remains the US FDA Preferred Term for this commodity. Rivaroxaban bears US NLM identifiers UMLS ID C1739768 and NCI Concept Code C77995. SMILES: CLC1SC(C(=O)NCC2OC(=O)N(C2)C2CCC(N3CCOCC3=O)CC2)CC1.

